What are the main applications of antibody engineering in modern medicine?
Antibody engineering is primarily used in modern medicine for developing targeted therapies for cancer, autoimmune diseases, and infectious diseases, designing diagnostic tools like ELISA and immunoassays, enhancing the efficacy of vaccines, and creating personalized medicine approaches through monoclonal and bispecific antibodies.
How does antibody engineering improve the efficacy of therapeutic drugs?
Antibody engineering enhances therapeutic drug efficacy by optimizing antibody specificity and affinity for target antigens, improving their ability to bind and neutralize pathogenic factors. It also extends half-life, reduces immunogenicity, and facilitates drug delivery by designing bispecific antibodies or antibody-drug conjugates, ultimately increasing the therapeutic index and effectiveness.
What are the common techniques used in antibody engineering?
Common techniques in antibody engineering include phage display, hybridoma technology, monoclonal antibody production, chimeric antibodies, humanization of antibodies, and site-directed mutagenesis. These methods improve specificity, affinity, and stability to enhance therapeutic potential.
What are the ethical considerations involved in antibody engineering?
Ethical considerations in antibody engineering include ensuring patient safety, obtaining informed consent for the use of human-derived antibodies, addressing the potential for unintended immune responses, and considering the impact of biotechnology patents on accessibility and affordability of treatments. Bioethics also evaluates the implications of using animals in antibody production.
What is the difference between monoclonal and polyclonal antibodies in the context of antibody engineering?
Monoclonal antibodies are identical antibodies produced from a single B-cell clone targeting one specific epitope, offering high specificity, while polyclonal antibodies are a mixture from multiple B-cell clones, targeting multiple epitopes on the same antigen, providing higher sensitivity but less specificity.